Permethrin
Elimite, Nix, Permethrin (permethrin) is a small molecule pharmaceutical. Permethrin was first approved as Nix on 1986-03-31. It is used to treat lice infestations and scabies in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| infections | D007239 |
| skin and connective tissue diseases | D017437 |
Trade Name
FDA
EMA
Elimite, Nix, Permethrin (discontinued: Nix, Permethrin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Permethrin
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ELIMITE | Aurobindo Pharma | N-019855 RX | 1989-08-25 | 1 products, RLD |
| NIX | MedTech Products | N-019918 OTC | 1990-05-02 | 1 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| elimite | New Drug Application | 2024-01-24 |
| good neighbor pharmacy lice treatment | ANDA | 2017-10-31 |
| good sense lice killing creme rinse | ANDA | 2022-11-21 |
| health mart lice treatment | ANDA | 2020-07-09 |
| leader lice treatment | ANDA | 2021-06-17 |
| lice treatment | ANDA | 2022-04-27 |
| nix | New Drug Application | 2021-12-02 |
| nix complete lice treatment | New Drug Application | 2020-04-23 |
| nix lice killing creme rinse | New Drug Application | 2022-02-07 |
| permethrin | ANDA | 2024-07-29 |
Show 2 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P03: Ectoparasiticides, incl. scabicides, insecticides and repellents
— P03A: Ectoparasiticides, incl. scabicides
— P03AC: Pyrethrines, incl. synthetic compounds, ectoparasiticides, incl. scabicides
— P03AC04: Permethrin
— P03AC54: Permethrin, combinations
HCPCS
No data
Clinical
Clinical Trials
61 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Scabies | D012532 | — | B86 | 2 | 3 | 10 | 2 | 3 | 20 |
| Lice infestations | D010373 | — | B85.2 | 1 | 2 | 6 | 2 | 3 | 14 |
| Malaria | D008288 | EFO_0001068 | B54 | — | — | 1 | 1 | 7 | 9 |
| Pediculus | D010374 | — | — | — | 2 | 1 | 1 | 3 | 7 |
| Tinea capitis | D014006 | — | B35.0 | — | 1 | 1 | 1 | 2 | 5 |
| Parasitic diseases | D010272 | EFO_0001067 | B88 | — | — | 1 | 2 | — | 3 |
| Impetigo | D007169 | EFO_1000714 | L01 | — | — | — | 1 | 1 | 2 |
| Trachoma | D014141 | — | A71 | — | 1 | — | 1 | — | 2 |
| Infections | D007239 | EFO_0000544 | — | — | — | 1 | 1 | — | 2 |
| Yaws | D015001 | EFO_0007548 | A66 | — | — | — | 1 | — | 1 |
Show 5 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | — | 1 | — | — | 1 |
| Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | — | — | 1 | — | — | 1 |
| Lyme disease | D008193 | — | A69.2 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 1 | 1 | — | — | — | 1 |
| Plasma cell neoplasms | D054219 | — | — | 1 | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | HP_0001903 | D64.9 | — | — | — | — | 2 | 2 |
| Tick-borne diseases | D017282 | — | — | — | — | — | — | 2 | 2 |
| Tick bites | D064927 | — | — | — | — | — | — | 2 | 2 |
| Filarial elephantiasis | D004605 | EFO_0007272 | B74.0 | — | — | — | — | 1 | 1 |
| Filariasis | D005368 | — | B74 | — | — | — | — | 1 | 1 |
| Elephantiasis | D004604 | EFO_0004711 | — | — | — | — | — | 1 | 1 |
| Masculinity | D057228 | — | — | — | — | — | — | 1 | 1 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 1 | 1 |
| Chest pain | D002637 | HP_0100749 | R07.9 | — | — | — | — | 1 | 1 |
| Chronic pain | D059350 | HP_0012532 | — | — | — | — | — | 1 | 1 |
Show 7 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Permethrin |
| INN | permethrin |
| Description | Permethrin is a cyclopropanecarboxylate ester in which the esterifying alcohol is 3-phenoxybenzyl alcohol and the cyclopropane ring is substituted with a 2,2-dichlorovinyl group and with gem-dimethyl groups. It has a role as a pyrethroid ester insecticide, a pyrethroid ester acaricide, an agrochemical, an ectoparasiticide and a scabicide. It is a member of cyclopropanes and a cyclopropanecarboxylate ester. It is functionally related to a 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1 |
Identifiers
| PDB | — |
| CAS-ID | 52645-53-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1525 |
| ChEBI ID | 34911 |
| PubChem CID | 40326 |
| DrugBank | DB04930 |
| UNII ID | 509F88P9SZ (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Permethrin
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,286 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,141 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use